1
Return

Letter: Beyond the Metrics: Translating Time in Range Gains into Global Health Equity. The Economic Case for Universal and Early Access to Diabetes Technology

delete2025-10-17
delete0
PRE
AI
A
Andrea Scaramuzza
I
Ivana Rabbone
DOI:10.1177/15209156251390815delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Diabetes Technology & Therapeutics

Journal

Diabetes Technology and Therapeutics cover
Diabetes Technology and Therapeutics
IF:
6.3
Papers:
2.9K
Citations:
7.5K

Organization

Cited Papers

Cited Papers

Citing Papers

Citing Papers